CRISPR Therapeutics AG CRSP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:10 PM EDT
120.99quote price arrow down-0.26 (-0.21%)
Volume
5,623
Close
121.25quote price arrow up+3.44 (+2.92%)
Volume
762,948
52 week range
79.31 - 220.20
Loading...
  • Open119.26
  • Day High122.25
  • Day Low116.91
  • Prev Close117.81
  • 52 Week High220.20
  • 52 Week High Date01/15/21
  • 52 Week Low79.31
  • 52 Week Low Date10/02/20

Key Stats

  • Market Cap9.239B
  • Shares Out76.20M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta2.24
  • YTD % Change-20.81

KEY STATS

  • Open119.26
  • Day High122.25
  • Day Low116.91
  • Prev Close117.81
  • 52 Week High220.20
  • 52 Week High Date01/15/21
  • 52 Week Low79.31
  • 52 Week Low Date10/02/20
  • Market Cap9.239B
  • Shares Out76.20M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta2.24
  • YTD % Change-20.81

RATIOS/PROFITABILITY

  • EPS (TTM)5.11
  • P/E (TTM)23.73
  • Fwd P/E (NTM)-16.77
  • EBITDA (MRQ)459.184M
  • ROE (MRQ)25.41%
  • Revenue (MRQ)901.76M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)49.52%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date10/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CRISPR Therapeutics AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed changes to genomic deoxyribonucleic acid (DNA). The Company has a portfolio of therapeutic programs in a range of disease areas, including...
Rodger Novak M.D.
Chairman
Samarth Kulkarni Ph.D.
Chief Executive Officer
Lawrence Klein Ph.D.
Chief Operating Officer
Michael Tomsicek
Chief Financial Officer
Tony Ho M.D.
Executive Vice President
James Kasinger J.D.
General Counsel
Address
Baarerstrasse 14
Zug
6300
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
NBIX
Neurocrine Biosciences Inc
95.05+0.78+0.83%
MEDP
Medpace Holdings Inc
195.24+4.48+2.35%
EXEL
Exelixis Inc
20.50+0.30+1.49%
SRPT
Sarepta Therapeutics Inc
90.54+3.07+3.51%
NTRA
Natera Inc
123.54-2.14-1.70%